Global Antithrombotic/Anticoagulant Drugs Market To Reach $27.3 Billion by 2021 From $18.9 Billion in 2016 - Global Analysis Report

Dublin, Sept. 19, 2016 -- Research and Markets has announced the addition of the "Antithrombotic/Anticoagulant Drugs - Technologies and Global Markets" report to their offering.

This report is a comprehensive business tool designed to provide an in-depth look at antithrombotic/anticoagulant drugs for various cardiovascular applications. The geographic scope of the report is global, with a special emphasis on individual regions such as the United States, Europe, Asia-Pacific and the rest of world. The report describes the industry, its relationship to the healthcare industry and its participants and future trends.

This report provides:

• An overview of the global market for antithrombotic/anticoagulant drugs, which is changing due to factors such as an aging population, an increase in thrombotic events, and recent advances in pharmaceuticals
• Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021
• Breakdowns of the market size of anticoagulants by revenue at manufacturers' sales levels, including low molecular weight heparins and oral anticoagulants, as well as breakdowns of antiplatelets and thrombin inhibitors
• Discussion of research and development of antithrombotic/anticoagulant treatments
• Profiles of top leaders in each of the market segments along with companies that are novel or have specific interest to the field

Categories discussed in the report include:

• Anticoagulants.
• Antiplatelets.
• Thrombin inhibitors.
  

All categories are discussed in detail, describing each segment, identifying current products on the market, measuring market size, identifying market drivers, forecasting for 2016 to 2021 and assessing the competitors their market shares.

Key Topics Covered:

1: Introduction
Study Goals And Objectives
Reasons For Doing This Study
Scope Of The Study
Methodology And Information Sources

2: Executive Summary
Executive Summary

3: Industry Overview
Major Developments
Sales Performance Of Major Drugs Projected Through 2020
Patent Analysis
Epidemic Of Cardiovascular Disease
Classification Of Cardiovascular Diseases
The Circulatory System
Conditions
Hemostasis (The Clotting Process)
Diseases Associated With Thromboembolism
Demographics

4: Anticoagulants
Overview
Products
Oral Anticoagulants (Vitamin K Antagonists)
Global Market Forecast
Competitive Analysis

5: Antiplatelets
Overview
Products
Global Market Forecast
Competitive Analysis

6: Thrombin Inhibitors
Overview
Products
Global Thrombin Inhibitor Market Forecast
Research And Development
Global Anticoagulant/Antithrombotic Market Forecast
Competitive Analysis

7: Company Profiles
Abbott Laboratories
Armetheon Inc.
Astrazeneca
Baxter International
Bayer AG
Biovascular Inc.
Boehringer Ingelheim Gmbh
Bristol-Myers Squibb Co.
CSL Behring
Daiichi Sankyo Co. Ltd.
Eli Lilly
Emisphere Technologies
F. Hoffmann-La Roche AG
Genentech
Glaxosmithkline
Johnson & Johnson
Ligand Pharmaceuticals Inc.
The Medicines Co.
Merck
Merrion Pharmaceuticals Ltd.
Microbix Biosystems Inc.
Novartis
ONO Pharmaceutical Co. Ltd.
Otsuka Pharmaceutical Co. Ltd.
Pfizer Inc.
Portola Pharmaceuticals
Revo Biologics Inc.
Sanofi
Santa Cruz Biotechnology Inc.
Servier Laboratories
Shire Pharmaceuticals
Sun Pharmaceuticals
TEVA Pharmaceuticals Ltd.

8: Appendix A: List Of Patents
Table 57 : List Of Patents On Antithrombotics And Anticoagulants, 2011-April 2016

9: Appendix B: Directory Of Companies Covered In This Report

For more information about this report visit http://www.researchandmarkets.com/research/czsthv/antithromboticant

Related Topics: Hematological Drugs

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]

         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716